Calcium/calmodulin-dependent protein kinase type II delta (CaMKIIδ), the predominant CaMKII isoform expressed in the heart, has been implicated in the progression of myocardial infarction-and pressure overload-induced pathological remodeling. However, the role of CaMKIIδ in volume overload (Vo) has not been explored. We have previously reported an activation of CaMKII during transition to HF in long-term VO. Here, we address whether CaMKIIδ is critically involved in the mortality, myocardial remodeling, and heart failure (HF) progression in response to VO. CaMKIIδ knockout (δ-Ko) and wildtype (WT) littermates were exposed to aortocaval shunt-induced VO, and the progression of adverse myocardial remodeling was assessed by serial echocardiography, histological and molecular analyses. The mortality rates during 10 weeks of VO were similar in δ-KO and WT mice. Both genotypes displayed comparable eccentric myocardial hypertrophy, altered left ventricle geometry, perturbed systolic and diastolic functions after shunt. Additionally, cardiomyocytes hypertrophy, augmented myocyte apoptosis, and up-regulation of hypertrophic genes were also not significantly different in δ-Ko versus WT hearts after shunt. Therefore, CaMKIIδ signaling seems to be dispensable for the progression of VO-induced maladaptive cardiac remodeling. Accordingly, we hypothesize that CaMKIIδ-inhibition as a therapeutic approach might not be helpful in the context of VO-triggered HF.
progressive contractile dysfunction and dilation in δ-KO and WT after shunt. To mice exhibited early pronounced myocardial dilatation and late contractile failure, but unchanged septum wall thickness, indicating an eccentric hypertrophy ( Fig. 2a-d ; Table 1 ). However, there were no significant differences between shunt-WT and -δ-KO mice. According to Laplace's law, LV mass-to-end-diastolic volume (EDV) ratio is inversely proportional to cardiac wall stress. LV mass-to-EDV ratio, calculated via echocardiography, was similarly decreased at 12 weeks post-shunt (≈17% decrease in shunt vs. sham, Fig. 2e ), indicating similar increases in cardiac wall stress in both genotypes. The heart rates were not different amongst all four groups (Fig. 2g ).
Strain rate imaging revealed functional deterioration after shunt in both genotypes. We used high-frequency speckle tracking echocardiography to quantify myocardial strain. Consistent with progressive deterioration of EF, the global longitudinal strain rate was significantly reduced in both genotypes at 16 weeks after shunt, indicating a progressive systolic dysfunction (Fig. 3a) . We also used speckle tracking to address www.nature.com/scientificreports www.nature.com/scientificreports/ whether CaMKIIδ loss would affect diastolic function post-shunt. The peak reverse longitudinal strain rate and radial diastolic peak velocity were markedly decreased in both genotypes at 16 weeks post-shunt, suggesting a comparable diastolic dysfunction (Fig. 3b ,c).
CaMKII deletion did not improve the histological and molecular signatures of 12 weeks
Vo-induced myocardial remodeling. Further analyses were performed at 12 weeks post-shunt, a time point corresponding to early deterioration of systolic function and hence early transition to HF. There was no difference in body weight among the 4 groups ( Table 2) . Being a biventricular VO model, both shunt groups displayed left and right ventricular hypertrophy compared to sham mice. However, no marked differences were found between the shunt-operated WT and δ-KO mice ( Table 2) . Moreover, lung weight-to-tibia length ratio was similarly increased in both genotypes after shunt, indicating a comparable pulmonary edema in the context of congestive HF ( Table 2) .
Overall morphology showed no apparent differences between shunt-operated WT and δ-KO hearts as indicated by H&E and picrosirius red staining ( Fig. 4a,b ). Wheat germ agglutinin-stained sections showed cardiomyocyte hypertrophy after shunt, and the cardiomyocytes minimal fiber diameter increased to a greater extent in WT (≈17%) than in δ-KO (≈9%) hearts, but the difference between shunt groups did not reach statistical significance (p = 0.57, Fig. 4c ). We also determined the extent of apoptotic cell death after shunt by TUNEL assay. Hearts from shunt-operated mice showed a marked increase of TUNEL-positive cells as compared to sham controls, but no marked difference between WT-shunt and δ-KO-shunt could be identified ( Fig. 4d) .
At the molecular level, shunt-subjected δ-KO and WT mice displayed comparable reactivation of the fetal cardiac gene program, including natriuretic peptide type A (Nppa) and natriuretic peptide type B (Nppb), and a trend towards down-regulation of sarcoplasmic reticulum Ca 2+ -ATPase-2a (Serca-2a) ( Fig. 5 ). Thus, CaMKIIδ deletion does not appear to significantly avert maladaptive cardiac remodeling during chronic VO. equal activation of CaMKII in δ-KO and WT hearts after shunt. To address whether CaMKII activation would be abated in δ-KO hearts, we used the commercially available anti-phospho-CaMKII antibody, which unfortunately does not distinguish the different CaMKII isoforms. Consistent with our previous results 2 , CaMKII activity, inferred from phospho-CaMKII levels, increased in WT hearts at 12 weeks post-shunt. Surprisingly, the www.nature.com/scientificreports www.nature.com/scientificreports/ CaMKII phosphorylation were also enhanced in δ-KO after shunt to nearly the same level seen in WT hearts, although complete loss of CaMKIIδ in cardiac extracts of δ-KO mice was confirmed ( Fig. 6a,b ). We also measured the phosphorylation of the CaMKII target sites, phospholamban (PLB)-Thr17 and ryanodine receptor WT-sham (n = 6) δ-KO-sham (n = 5) WT-shunt (n = 11) δ-KO-shunt (n = 9) BW (g)
28.80 ± 1.07 28.44 ± 0.72 29.22 ± 1.12 29.37 ± 1.02 www.nature.com/scientificreports www.nature.com/scientificreports/ (RyR2)-Ser2814, by Western blot analyses. Both phosphorylation sites were slightly but not significantly reduced in δ-KO vs. WT hearts ( Fig. 6a,b ). Immunoblotting analysis revealed no difference in CaMKIIγ protein levels between δ-KO and WT hearts, in both sham and shunt mice ( Fig. 6a,b ).
Consistent with protein data, CamkIIδ mRNA was markedly induced in WT hearts after shunt ( Fig. 6c ). To address whether the other CaMKII isoforms could compensate for CaMKIIδ deletion, we quantified their expression levels. Whereas CamkIIα was not detectable, CamkIIβ and CamkIIɣ were not differentially expressed in both genotypes in sham and shunt (Fig. 6c ).
Discussion
The present study investigated the relevant role of the predominant cardiac CaMKII isoform, CaMKIIδ, in the setting of VO and showed that: [1] VO-triggered adverse myocardial remodeling was not attenuated upon CaMKIIδ deletion. Consistently, mortality rates after shunt were similar in δ-KO and WT mice. [2] Despite efficient CaMKIIδ deletion, comparable CaMKII activity was detected in δ-KOand WT-sham that significantly but similarly increased after shunt.
Previously, we reported that the Ca 2+ cycling in VO model is not disturbed and the myocardial remodeling, in comparison to PO, is more favorable at least in its acute phase 3, 18 . While stimulation of Ca 2+ cycling is induced in PO to increase the myofilament activation, VO is compensated by the Frank-Starling mechanism, which is Ca 2+ cycling-independent. The changes in PO are partially and very early mediated by CaMKIIδ activation, leading to disturbed intracellular Ca 2+ homeostasis. In contrast, VO shows no sign of early CaMKIIδ activation 3 . At later stages, disturbed Ca 2+ cycling, as evidenced by CaMKIIδ activation and protein kinase B/AKT inactivation, are visible in the VO model and probably contribute to the HF phenotype 2 , suggesting that maintenance of AKT and/ or antagonizing CaMKII signalings might be promising therapeutics to avert maladaptive remodeling in response to VO. Consistently, VO-triggered pathological remodeling is aggravated in Akt-KO mice 2 , and hence small molecules to retain AKT signaling might be a novel therapy for the treatment of congestive HF 19 .
However, little is known about the role of CaMKII in VO. In cardiomyocytes, CaMKII phosphorylates and regulates several key proteins involved in intracellular Ca 2+ signaling, including PLB, RyR2 and the L-type Ca 2+ channel 20, 21 . CaMKII expression and activity increase in patients and animal models of HF 3, 22, 23 . CaMKIIδ inactivates histone deacetylase 4, leading to transcriptional activation of myocyte enhancer factor 2 and up-regulation of hypertrophic marker genes 24 . Consistently CaMKIIδ transgenic mice display pathological cardiac hypertrophy 25, 26 , whereas genetic CaMKIIδ deletion mitigates adverse LV remodeling triggered by PO, Gαq expression, β-adrenergic stimulation, and ischemia/reperfusion [12] [13] [14] [15] [16] [17] .
VO has several simultaneous events including increased adrenergic drive, cardiomyocyte oxidative stress, and an intense inflammatory response [27] [28] [29] . CamKIIδ is considered a nexus between detrimental neurohumoral activities and remodeling, and was reported to mediate inflammation and oxidative stress [30] [31] [32] . Therefore, we anticipated attenuated progression to HF in δ-KO mice exposed to chronic VO. However, this was not clearly supported by the present study. Here we showed that CaMKIIδ deletion neither improved the survival pattern nor mitigated adverse myocardial remodeling, as evidenced by echocardiographic, gravimetric, histological, and molecular analyses, suggesting that induced CaMKII activity during early HF transition in long-term VO is secondary to the underlying pathologies.
Although PLB-Thr17 and RyR2-Ser2814 are endogenous substrates of CaMKII, phosphorylation at these sites were mildly decreased in δ-KO sham vs. WT sham. These results are consistent with previous reports 12, 31 , and suggest that other kinases or CaMKII isoforms could compensate for phosphorylation at these sites. However, neither CaMKIIβ nor CaMKIIɣ showed any differential regulation upon CaMKIIδ deletion. Inconsistent with our data, Ling et al. 14 have demonstrated massive decreased p-PLB-Thr17 and p-RyR2-Ser2814 levels in δ-KO mice. This discrepancy could be mice strain-dependent or due to different δ-KO strategies used. Here we used δ-KO www.nature.com/scientificreports www.nature.com/scientificreports/ mice generated via targeted deletion of exons 1-2 resulting in no translation of any residual CaMKII peptides 12 . In contrast, Ling et al. 14 generated δ-KO mice by deletion of exons 9-11. Although they showed that CaMKIIδ was efficiently and completely deleted in δ-KO mice on the protein levels, the complete uncropped blots were not published and therefore we cannot rule out that the upstream exons, encoding the catalytic domains, would be translated giving a residual N-terminal peptide that might exert a dominant-negative effect on CaMKIIɣ and hence experiencing massive reduction of p-PLB-Thr17 and p-RyR2-Ser2814 levels that are comparable to that seen in CaMKIIδ/γ double KO mice 31 .
A striking observation of our study is the comparable CaMKII activity in δ-KO and WT hearts as inferred from CaMKII autophosphorylation. We can speculate that the induced CaMKII phosphorylation after shunt is due to increased CaMKIIγ activity, but not CaMKIIδ, suggesting that CaMKIIδ is entirely dispensable for VO-triggered adverse remodeling. One can also assume that CaMKIIδ deletion might be functionally compensated by CaMKIIγ. One of these assumptions might explain the lack of the beneficial effect of CaMKIIδ deletion on myocardial remodeling after shunt. Although we did not find an up-regulation of CaMKIIγ protein or mRNA in δ-KO mice, this does not exclude a possible role of CaMKIIγ activity in cardiac adaptation to VO. Indeed, Backs group has recently reported a redundant role of cardiac CaMKIIγ and CaMKIIδ isoforms in the context of PO and ischemia/reperfusion injuries 31, 33 . Thus, further investigations are warranted to address whether CaMKIIγ-KO or CaMKIIδ/γ double KO mice would be protected against pathological remodeling triggered by VO.
Apoptosis is one of the pathophysiological features of maladaptive remodeling where it entails detrimental effects on cardiac contractility 34 . The CaMKIIδ has two isoforms generated by alternative splicing, viz, the anti-apoptotic nuclear δB and the pro-apoptotic cytosolic δC isoforms 30, 35, 36 . Here, we used δ-KO mouse model, lacking both δB and δC splice variants, and could show that cardiac apoptosis was similarly increased in shunt-operated δ-KO and WT hearts, suggesting that the anti-apoptotic effect of δC deletion could be buffered by pro-apoptotic effect of δB loss. www.nature.com/scientificreports www.nature.com/scientificreports/ As opposed to the more extensively studied PO, there are no approved medical therapies to attenuate the adverse LV remodeling in the clinical VO of MR or AR because of limited VO experimental models available to efficiently mimic the chronic course of pure VO. This study was conducted using an established, reliable, and easily reproducible shunt model that induces pure VO, a condition that does not involve concomitant increases in PO, and therefore has helped to dissect the pathophysiology of VO. Although we consistently used 23-gauge needle to create the aorto-caval shunt, it is still difficult to control the shunt volume and we cannot rule out that shunt tends to distort, resulting in luminal stenosis and narrowing. However, LVEDD, SV and CO at 1-week post-surgery (early time point) were comparably increased in shunt-operated δ-KO and WT hearts, indicating a comparable shunt size and a similar degree of VO development in δ-KO and WT mice. Noteworthy, the severity of AR in human is classified according to the degree of SV induction and EF reduction, in which an increased SV by more than 65%, and a deteriorated cardiac function is correlated with severe degree AR that warrants surgical intervention. Interestingly, our shunt model experienced an increased SV by ≈70% and ≈63% at 1-week post-shunt in δ-KO and WT hearts, respectively, and a progressive EF deterioration. Therefore, we assume, that the degree of VO-triggered in our shunt model simulates the clinical situation seen in severe AR.
The VO is characterized by increased extracellular matrix turnover. Several reports showed a predominant inflammatory response immediately after shunt creation, which releases inflammatory mediators capable of activating matrix metalloproteinases that degrade collagen and therefore leads to eccentric hypertrophy and LV dilatation that even precedes cardiomyocytes elongation in VO model 37, 38 . Consistently, both shunt-operated δ-KO and WT mice developed early LV dilatation but late functional deterioration. Beside systolic impairment, both shunt-operated groups experienced diastolic dysfunction as evidenced by deteriorated strain rate. Previously we and others have reported that VO induces an increased titin stiffness 2,39 that could, on one side, limit eccentric hypertrophy and further myocardial dilatation. On the other side, increase titin-based sarcomere stiffness could limit active relaxation and passive distension and is therefore responsible for diastolic dysfunction seen in VO model.
The VO-triggered mortality is mainly due to cardiac dysfunction especially at long-term VO, when the cardiac function is impaired. But sudden cardiac death and fatal arrhythmias cannot be ruled out. Moreover, some mice would be presumably unable to compensate for the abrupt increase in preload and die of acute or subacute congestive heart failure at early phase VO. Noteworthy, shunt-operated mice exhibited higher mortality and severe remodeling than we have reported previously 3 , which is mainly due to strain and gender differences. While FVB/N mice show a mild myocardial remodeling following hemodynamic stress that takes longer time to develop HF, C57BL/6N line exhibits aggressive myocardial remodeling associated with higher mortality that progresses rapidly to congestive HF 40, 41 . Moreover, males experience severe myocardial remodeling, associated with marked chamber dilatation and higher mortality. In contrast, females can better compensate for VO and show less dilatation and mortality 42 . In our previous study 3 we used FVB/N female mouse line, whereas here we intentionally used both genders, to ensure reproducible data, in C57BL/6N substrain to investigate the effect of CaMKIIδ deletion on relatively severe form of VO-triggered myocardial remodeling.
In conclusion, we showed that, despite the reported relevance of CaMKII as a biomarker in HF patients, geometric, functional, and structural remodeling upon deletion of CaMKIIδ were not attenuated at early or late phases of VO. Our study not only excludes the critical role of CaMKIIδ in initiation or progression of adverse myocardial remodeling triggered by VO but also provides critical information for inhibition of CaMKIIδ as a potential therapeutic target for the maintenance of cardiac function in the setting of VO.
Materials and Methods
Mice. All investigations were approved by the responsible Institutional Review Board (Lower Saxony State Office for Consumer Protection and Food Safety (LAVES), conforms to the Guide for the Care and Use of Laboratory Animals (NIH publication No. 85-23, revised 1996), and was performed in accordance with the ethical standards laid down in the Declaration of Helsinki 1964. As previously described, the CaMKIIδ-KO mice 12 were generated by breeding floxed CaMKIIδ with CAG-Cre transgenic mice 43 to give heterozygous CaMKIIδ +/− mice that were intercrossed to each other to obtain global homozygous CaMKIIδ −/− mice (δ-KO). In this study, we analyzed male and female δ-KO and WT littermates on C57BL/6N genetic background.
Aortocaval shunt. Shunt surgery was done as previously described 44 . Briefly, 8-week-old δ-KO and WT littermates were anesthetized using isoflurane insufflation and a longitudinal abdominal incision was made to expose the infrarenal abdominal aorta and inferior vena cava. A 23-gauge needle was inserted into the infrarenal aorta at a 45degree angle and passed through to the vena cava, creating the shunt. After needle withdrawal, the aortic puncture was sealed using cyanoacrylate (Pattex, Düsseldorf, Germany). In successful shunt creation, pulsatile flow of oxygenated blood from the infrarenal aorta into the inferior vena cava could be visualized. The abdomen was then closed, and the mice were kept on a heating plate until full recovery from anesthesia. Sham animals underwent the same procedure except for the puncture of the vessels. transthoracic echocardiography. The mice were anesthetized using 1.5% isoflurane, and echocardiography was performed using a VS-VEVO 660/230 (Visual Sonics, Toronto, Canada). 2D guided M-mode images were recorded in the long-axis view at the left mid-ventricular level. Strain analysis was performed as described recently 45 . The Echo measurements and analyses were carried out by 2 independent scientists who were completely blind towards group assignment.
Histological analysis. The hearts were fixed in 4% buffered formaldehyde overnight, paraffin-embedded, sectioned (5 µm), and stained with hematoxylin-eosin (H&E) for cell morphology. For minimal cardiomyocyte fiber diameter, sections were stained with fluorescein-conjugated wheat germ agglutinin (WGA-Alexa Fluor 594,
